Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
Saved in:
| Title: | Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks. |
|---|---|
| Authors: | Suárez-García I; Infectious Diseases Group, Department of Internal Medicine, Hospital Universitario Infanta Sofia, FIIB HUIS HUHEN, Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Clinical Department, Facultad de Medicina, Salud y Deporte, Universidad Europea de Madrid, Madrid, Spain., Alejos B; Independent Researcher, Madrid, Spain., Moreno C; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain., Martín Torres J; HIV Unit, Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain., Masiá M; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Section, Department of Internal Medicine, Hospital General Universitario de Elche, Alicante, Spain.; Department of Clinical Medicine, Universidad Miguel Hernández de Elche, Alicante, Spain., García-Fraile LJ; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Unit, Department of Internal Medicine, Hospital Universitario de La Princesa, Madrid, Spain., Riera M; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Department of Internal Medicine, Section of Infectious Diseases, Hospital Universitario Son Espases-IDISBA, Palma, Spain., Dalmau D; HIV/STI/PrEP Unit, Infectious Disease Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain.; Department of Medicine, Universitat de Barcelona, Barcelona, Spain., Rodríguez-Rosado R; Department of Internal Medicine, Hospital Universitario Severo Ochoa, Madrid, Spain., Muga R; Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Moreno S; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, Ramón y Cajal University Hospital, IRYCIS, Madrid, Spain.; Department of Medicine, Universidad de Alcalá, Madrid, Spain., Jarrín I; CIBER de Enfermedades Infecciosas (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain. |
| Corporate Authors: | CoRIS cohort |
| Source: | The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2025 Mar 03; Vol. 80 (3), pp. 682-691. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2091 |
|---|---|
| DOI: | 10.1093/jac/dkae456 |
